1,023 reports of this reaction
6.1% of all ROCURONIUM BROMIDE reports
#3 most reported adverse reaction
DRUG INEFFECTIVE is the #3 most commonly reported adverse reaction for ROCURONIUM BROMIDE, manufactured by Fresenius Kabi USA, LLC. There are 1,023 FDA adverse event reports linking ROCURONIUM BROMIDE to DRUG INEFFECTIVE. This represents approximately 6.1% of all 16,854 adverse event reports for this drug.
Patients taking ROCURONIUM BROMIDE who experience drug ineffective should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG INEFFECTIVE is moderately reported among ROCURONIUM BROMIDE users, representing a notable but not dominant share of adverse events.
In addition to drug ineffective, the following adverse reactions have been reported for ROCURONIUM BROMIDE:
The following drugs have also been linked to drug ineffective in FDA adverse event reports:
DRUG INEFFECTIVE has been reported as an adverse event in 1,023 FDA reports for ROCURONIUM BROMIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG INEFFECTIVE accounts for approximately 6.1% of all adverse event reports for ROCURONIUM BROMIDE, making it one of the most commonly reported side effect.
If you experience drug ineffective while taking ROCURONIUM BROMIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.